Video Capsule Endoscopy in Patients with Jejunal Anastomosis
A patient with a patulous (dilated) loop of small bowel from a jejunal anastomosis can undergo video capsule endoscopy, but requires pre-procedure assessment with a patency capsule to minimize retention risk, as altered surgical anatomy represents a known risk factor for capsule retention.
Risk Assessment and Precautions
The presence of a jejunal anastomosis creates altered small bowel anatomy that warrants careful consideration before proceeding with capsule endoscopy. While the 2017 Gastroenterology guidelines recommend patency capsule use specifically for "known or suspected strictures" 1, the European Society of Gastrointestinal Endoscopy (ESGE) 2022 guidelines extend this recommendation to established Crohn's disease patients to decrease retention rates 2. Your patient's surgical anatomy falls into a similar risk category.
Key Evidence on Surgical Anatomy:
Successful cases exist: Research demonstrates that capsule endoscopy can be performed safely in patients with altered upper GI anatomy, including dual intestinal loop configurations (Billroth-II, Whipple, Roux-en-Y) 3. In one series, all patients with altered anatomy achieved complete small intestinal imaging without complications 3.
Retention risk is real: Case reports document capsule retention at anastomotic sites, particularly when unrecognized strictures exist 4, 5. One patient with previous bowel resection developed small bowel obstruction requiring surgical removal of the retained capsule 5.
Patency capsule validation: When patients with known or suspected strictures passed an intact patency capsule within 72 hours, subsequent video capsule endoscopy was performed safely in 100% of cases 6. This provides direct evidence of functional patency.
Recommended Approach
Step 1: Patency Capsule Testing
Administer a patency capsule first. If the patient excretes an intact patency capsule within 72 hours without adverse events, this confirms functional patency and allows safe progression to video capsule endoscopy 6.
Step 2: Consider Delivery Method
If patency is confirmed:
- Oral ingestion is preferred: A 2015 study showed 81% completion rate with oral ingestion in post-surgical patients, with rapid gastric transit and no retention events 7. This approach is favored given its better risk and cost profile.
- Endoscopic placement is alternative: If oral ingestion fails or concerns exist about transit, endoscopic deployment using a delivery device can be performed safely 3, though completion rates may be slightly lower (62.5% in one series) 7.
Step 3: Extended Monitoring
Given altered anatomy, confirm capsule reaches the small bowel within 1 hour of ingestion and continue study to full battery life 1. This is particularly important as altered anatomy may affect transit times.
Critical Caveats
Do not proceed if:
- The patient has obstructive symptoms
- Imaging suggests a tight stricture at the anastomosis
- The patency capsule is not excreted intact or causes symptoms
Common pitfall: Assuming all post-surgical anatomy is safe without functional assessment. The anastomotic site itself can develop strictures over time, particularly if the original surgery was for radiation enteritis, inflammatory conditions, or ischemic disease 4.
The consent process must explicitly disclose the potential for capsule retention and possible need for surgical or endoscopic retrieval 1.